These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14609670)

  • 41. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.
    Tracy MA; Ward KL; Firouzabadian L; Wang Y; Dong N; Qian R; Zhang Y
    Biomaterials; 1999 Jun; 20(11):1057-62. PubMed ID: 10378806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Degradation behaviour of self-reinforced 80L/20G PLGA devices in vitro.
    Välimaa T; Laaksovirta S
    Biomaterials; 2004; 25(7-8):1225-32. PubMed ID: 14643596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
    Passerini N; Craig DQ
    J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Copolymerization of D,L-lactide and glycolide in supercritical carbon dioxide with zinc octoate as catalyst.
    Mazarro R; de Lucas A; Gracia I; Rodríguez JF
    J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):196-203. PubMed ID: 17854066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
    Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
    Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.
    Ma X; Oyamada S; Wu T; Robich MP; Wu H; Wang X; Buchholz B; McCarthy S; Bianchi CF; Sellke FW; Laham R
    J Biomed Mater Res A; 2011 Mar; 96(4):632-8. PubMed ID: 21268237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PLGA/Ag nanocomposites: in vitro degradation study and silver ion release.
    Fortunati E; Latterini L; Rinaldi S; Kenny JM; Armentano I
    J Mater Sci Mater Med; 2011 Dec; 22(12):2735-44. PubMed ID: 22002470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: I. Synthesis and characterization.
    Wang N; Wu XS; Li C; Feng MF
    J Biomater Sci Polym Ed; 2000; 11(3):301-18. PubMed ID: 10841281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide).
    Kreitz MR; Domm JA; Mathiowitz E
    Biomaterials; 1997 Dec; 18(24):1645-51. PubMed ID: 9613812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel polyphosphazene/poly(lactide-co-glycolide) blends: miscibility and degradation studies.
    Ibim SE; Ambrosio AM; Kwon MS; El-Amin SF; Allcock HR; Laurencin CT
    Biomaterials; 1997 Dec; 18(23):1565-9. PubMed ID: 9430340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Degradation of poly (DL-lactic acid-co-glycolic acid) containing calcium carbonate and hydroxyapatite fillers--effect of size and shape of the fillers--.
    Tsunoda M
    Dent Mater J; 2003 Sep; 22(3):371-82. PubMed ID: 14621002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
    Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
    Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and characterization of nanoparticles containing an antihypertensive agent.
    Leroueil-Le Verger M; Fluckiger L; Kim YI; Hoffman M; Maincent P
    Eur J Pharm Biopharm; 1998 Sep; 46(2):137-43. PubMed ID: 9795032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of divalent cations on pore formation and degradation of poly(D,L-lactide-co-glycolide).
    Fredenberg S; Reslow M; Axelsson A
    Pharm Dev Technol; 2007; 12(6):563-72. PubMed ID: 18161629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.
    Engwicht A; Girreser U; Müller BW
    Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Internal morphology of poly(D,L-lactide-co-glycolide) BCNU-loaded microspheres. Influence on drug stability.
    Painbeni T; Venier-Julienne MC; Benoit JP
    Eur J Pharm Biopharm; 1998 Jan; 45(1):31-9. PubMed ID: 9689533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels.
    Wen X; Tresco PA
    Biomaterials; 2006 Jul; 27(20):3800-9. PubMed ID: 16564567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ganciclovir on the hydrolytic degradation of poly(lactide-co-glycolide) microspheres.
    Chen X; Ooi CP; Lim TH
    J Biomater Appl; 2006 Jan; 20(3):287-302. PubMed ID: 16364967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.